Characterization of novel L-asparaginases having clinically safe profiles from bacteria inhabiting the hemolymph of the crab, Scylla serrata (Forskål, 1775)
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
No. 441/2020/KSCSTE
Kerala State Council for Science, Technology and Environment
MBT/HLT/23
CMFRI
CSIR-UGC JRF
Council of Scientific and Industrial Research, India
PubMed
35138564
DOI
10.1007/s12223-022-00952-x
PII: 10.1007/s12223-022-00952-x
Knihovny.cz E-zdroje
- MeSH
- asparaginasa MeSH
- Bacteria genetika MeSH
- glutaminasa MeSH
- hemolymfa MeSH
- krabi * MeSH
- lidé MeSH
- protinádorové látky * terapeutické užití MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- asparaginasa MeSH
- glutaminasa MeSH
- protinádorové látky * MeSH
L-asparaginase (ASNase) is the principal chemotherapeutic agent against different blood cancers. The risks associated with current clinical preparations demand screening for novel ASNases. Accordingly, the study was conducted to shortlist ASNases having clinically safer profiles from a novel niche, namely, microbes in the gut and hemolymph of apparently healthy Scylla serrata. A four-step strategic approach incorporating the essential requirements for clinically safer profiles was followed. The initial step through plate assay showed five (9.61%) potential ASNase producers. The relative prevalence of ASNase producers was higher in hemolymph (13.33%) than gut (4.5%). The positive isolates were identified as Priestia aryabhattai, Priestia megaterium, Bacillus altitudinis, Shewanella decolorationis, and Chryseomicrobium amylolyticum. Quantitative profiles revealed high ASNase production (114.29 to 287.36 U/mL) without any optimization, with an added advantage of the extracellular production. The second step for substrate specificity studies revealed the absence of L-glutaminase and urease activities in ASNases from C. amylolyticum and P. megaterium, the most desirable properties for safe clinical applications. This is the first report of glutaminase and urease-free ASNase from these two bacteria. The third step ensured type II nature of selected ASNases, the targeted form in clinical applications. The fourth step confirmed the activity and stability in human physiological conditions. Altogether, the results revealed two potential ASNases with clinically compatible profiles.
Zobrazit více v PubMed
Akhitha MB, Sumithra TG, Reshma KJ, Anusree VN, Neethu BR, Amala PV, Ratheesh KR, Soni KB, Sanil NK (2021) Analysis of nonribosomal peptide synthetase genes in hemolymph microbes of marine crabs. Arch Microbio 203:1251–1258 DOI
Akilandeswari K, Kavitha K, Vijayalakshmi M (2012) Production of bioactive enzyme L-asparaginase from fungal isolates of water sample through submerged fermentation research. Int J Pharm Pharm Sci 4:363–366
Alrumman SA, Mostafa YS, Al-izran KA. et al. (2019) Production and anticancer activity of an L-asparaginase from Bacillus licheniformis isolated from the Red Sea, Saudi Arabia. Sci Rep 9:3756. https://doi.org/10.1038/s41598-019-40512-x
Ashok A, Doriya K, Vithal JR, Qureshi A, Anoop Kumar AT, Santhosh DK (2019) Microbes producing L-asparaginase free of glutaminase and urease isolated from extreme locations of Antarctic soil and moss. Sci Rep 9:1423. https://doi.org/10.1038/s41598-018-38094-1 PubMed DOI PMC
Asselin B, Rizzari C (2015) Asparaginase pharmacokinetics and implications of therapeutic drug monitoring. Leuk Lymphoma 56:2273–2280 PubMed DOI PMC
Azra MN, Ikhwanuddin M (2016) Review of maturation diets for mud crab genus Scylla broodstock: present research, problems and future perspective. Saudi J Biol Sci 23:257–267. https://doi.org/10.1016/j.sjbs.2015.03.011 PubMed DOI
Bergey D, Whitman W, Goodfellow M, Kaampfer P, Busse H (2012) Bergey’s manual of systematic bacteriology. Springer, New York
Bhargavi M, Jayamadhuri R (2016) Isolation and screening of marine bacteria producing anti-cancer enzyme L-asparaginase. Am J Mar Sci 4:1–3. https://doi.org/10.12691/marine-4-1-1 DOI
Brumano LP, Da Silva FVS, Costa-Silva TA, Apolinário AC, Santos JHPM, Kleingesinds EK, Monteiro G, Rangel-Yagui CDO, Benyahia B, Junior AP (2019) Development of L-asparaginase biobetters: current research status and review of the desirable quality. Bioeng Biotechnol 6:212. https://doi.org/10.3389/fbioe.2018.00212 DOI
Cooney DA, Capizzi R, Handschumacher RE (1970) Evaluation of L-asparagine metabolism in animals and man. Cancer Res 30:929–935 PubMed
Dantas RC, Caetano LF, Torres ALS, Alves MS, Silva ETMF, Teixeira LPR, Teixeira DC, Moreira RA, Fonseca MHG, Neto SG, Martins LT, Furtado GP, Tavares KCS (2019) Expression of a recombinant bacterial L-asparaginase in human cells. BMC Res Notes 12:794. https://doi.org/10.1186/s13104-019-4836-5 PubMed DOI PMC
Doriya K, Kumar DS (2016) Isolation and screening of l-asparaginase free of glutaminase and urease from fungal sp. Biotech 6:1–10. https://doi.org/10.1007/s13205-016-0544-1 DOI
Duperthuy M, Schmitt P, Garzon E, Caro A, Rosa RD, Le Roux F et al (2011) Use of OmpU porins for attachment and invasion of Crassostrea gigas immune cells by the oyster pathogen Vibrio splendidus. Proc Natl Acad Sci USA 108:2993–2998. https://doi.org/10.1073/pnas.1015326108 PubMed DOI PMC
El-Naggar NA, Deraz S, Soliman H, El-Deeb NM, El-Ewasy SM (2016) Purification, characterization, cytotoxicity and anticancer activities of L-asparaginase, anti-colon cancer protein, from the newly isolated alkaliphilic Streptomyces fradiae NEAE-82. Sci Rep 6:32926. https://doi.org/10.1038/srep32926 PubMed DOI PMC
Erva RR, Goswami AN, Suman P, Vedanabhatla R, Rajulapati SB (2016) Optimization of L-asparaginase production from novel Enterobacter sp. by submerged fermentation using response surface methodology. Prep Biochem Biotechnol 47:219–228. https://doi.org/10.1080/10826068.2016.1201683 PubMed DOI
Essghaier B, Dhieb C, Rebib H, Ayari S, Boudabous ARA, Sadfi-Zouaoui N (2014) Antimicrobial behavior of intracellular proteins from two moderately halophilic bacteria: strain J31 of Terribacillus halophilus and strain M3–23 of Virgibacillus marismortui. J Plant Pathol Microb. 5:214. https://doi.org/10.4172/2157-7471.1000214 DOI
Feng Y, Liu S, Jiao Y, Wang Y, Wang M, Du G (2019) Gene cloning and expression of the L-asparaginase from Bacillus cereus BDRD-ST26 in Bacillus subtilis WB600. J Biosci Bioeng 127:418–424. https://doi.org/10.1016/j.jbiosc.2018.09.007 PubMed DOI
Fungaro MHP, Maccheroni Jr W (2002) Genetic improvement for enzyme production applied to the food industry In: Melo IS, Valadares-Inglis MC, Nass LL, Valois ACC (eds) Embrapa Meio Ambiente. Jaguariúna Genetic Resources and Improvement-Microorganism. Jaguariúna: Embrapa Meio Ambiente pp 426–453
Gomez-Gil B, Roque A, Lacuesta B, Rotllant G (2010) Diversity of vibrios in the hemolymph of the spider crab Maja brachydactyla. J Appl Microbiol 109:918–926. https://doi.org/10.1111/j.1365-2672.2010.04718.x PubMed DOI
Goswami R, Hegde K, Veeranki VD (2015) Production and characterization of novel glutaminase free recombinant L-asparaginase II of Erwinia carotovora subsp. Atroseptica SCRI 1043 in E. coli BL21 (DE3). Brit Microbiol Res J 6:95–112. https://doi.org/10.9734/BMRJ/2015/13867 DOI
Han S, Jung J, Park W (2014) Biochemical characterization of L-asparaginase in NaCl-tolerant Staphylococcus sp. OJ82 isolated from fermented seafood. J Microbiol Biotechnol 24(8):1096–1104. https://doi.org/10.4014/jmb.1405.05021
Hovda MB, Lunestad BT, Fontanillas R, Rosnes JT (2007) Molecular characterization of the intestinal microbiota of farmed Atlantic salmon (Salmo salar L.). Aquacult 272:581–588. https://doi.org/10.1016/j.aquaculture.2007.08.045 DOI
Husain I, Sharma A, Kumar S, Malik F (2016a) Purification and characterization of glutaminase free asparaginase from enterobacter cloacae: in-vitro evaluation of cytotoxic potential against human myeloid leukemia HL-60 cells. PLoS One 11(2):e0148877. https://doi.org/10.1371/journal.pone.0148877 PubMed DOI PMC
Husain I, Sharma A, Kumar S, Malik F (2016b) Purification and characterization of glutaminase free asparaginase from Pseudomonas otitidis: induce apoptosis in human leukemia MOLT-4 cells. Biochimie 121:38–51. https://doi.org/10.1016/j.biochi.2015.11.012 PubMed DOI
Janda MJ, Abbott SL (2007) 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: pluses, perils, and pitfalls. J Clin Microbiol 45:2761–2764. https://doi.org/10.1128/JCM.01228-07 PubMed DOI PMC
Jennings MP, Beacham IR (1990) Analysis of the Escherichia coli gene encoding L-asparaginase II, ansB, and its regulation by cyclic AMP receptor and FNR proteins. J Bacteriol 172:1491–1498. https://doi.org/10.1128/jb.172.3.1491-1498.1990 PubMed DOI PMC
Jiang J, Batra S, Zhang J (2021) Asparagine: A metabolite to be targeted in cancers asparagine: a metabolite to be targeted in cancers. Metabolites 11(6):402. https://doi.org/10.3390/metabo11060402 PubMed DOI PMC
Kumar S, Dasu V, Pakshirajan K (2010) Localization and production of novel L-asparaginase from Pectobacterium carotovorum MTCC 1428. Process Biochem 45:223–229. https://doi.org/10.1016/j.procbio.2009.09.011 DOI
Kumar S, Venkata Dasu V, Pakshirajan K (2011) Purification and characterization of glutaminase-free l-asparaginase from Pectobacterium carotovorum MTCC 1428. Bioresour Technol 102:2077–2082. https://doi.org/10.1016/j.biortech.2010.07.114 PubMed DOI
Mahajan RV, Saran S, Kameswaran K et al (2012) Bioresour Technol 125:11–16. https://doi.org/10.1016/j.biortech.2012.08.086 PubMed DOI
Mashburn LT, Wriston JC Jr (1964) Tumor inhibitory effect of l-asparaginase from Escherichia coli. Arch Biochem Biophys 105:450–452. https://doi.org/10.1016/0003-9861(64)90032-3
Michalska K, Jaskolski M (2006) Structural aspects of L-asparaginases, their friends and relations. Acta Biochim Pol 53:627–640 PubMed DOI
Mohamed A, Elshal MF, Kumosani TA, Alia MA (2015) Purification and characterization of asparaginase from Phaseolus vulgaris seeds Saleh. ECAM 2015:1–6. https://doi.org/10.1155/2015/309214 DOI
Nagarethinam S, Nagappa AN, Udupa N, Rao V (2012) Microbial L-asparaginases and its future prospects. Asian J Med Res 1:159–168
Prakash P, Singh HR, Jha SK (2020) Production, purification and kinetic characterization of glutaminase free anti-leukemic L-asparaginase with low endotoxin level from novel soil isolate. Prep Biochem Biotechnol 50:260–271. https://doi.org/10.1080/10826068.2019.1692221 PubMed DOI
Rizzo C, Giudice AL (2018) Marine invertebrates: Underexplored sources of bacteria producing biologically active molecules. Diversity 10(3):52. https://doi.org/10.3390/d10030052
Roy MP, Das V, Patra A (2019) Isolation, purification and characterization of an extracellular L-asparaginase 3 produced by a newly isolated Bacillus megaterium strain MG1 from the water bodies of 4 Moraghat forest, Jalpaiguri, India. J Gen Appl Microbiol 19:137–144. https://doi.org/10.2323/jgam.2018.07.004 DOI
Schorn MA, Jordan PA, Podell S, Blanton JM, Agarwal V, Biggs JS, Allen EE, Moore BS (2019) Comparative genomics of Cyanobacterial symbionts reveals distinct, specialized metabolism in tropical Dysideidae sponges. MBio 10:e00821-e919. https://doi.org/10.1128/mBio.00821-19 PubMed DOI PMC
Setiawan R, Larasati DR (2019). Screening of bacteria producing asparaginase free of glutaminase and urease from hot springs in West Sulawesi. Biosaintifika 11(2):218–225
Sharafi Z, Baratia M, Khoshayandb MR, Adrang S (2017) Screening for Type II L-asparaginases: lessons from the genus Halomonas. Iran J Pharm Res 16:1565–1573
Shirazian P, Asad S, Amoozegar MA (2016) The potential of halophilic and halotolerant bacteria for the production of antineoplastic enzymes: L-asparaginase and L-glutaminase. Excli J 15:268–279. https://doi.org/10.17179/excli2016-146
Singh Y, Kumar RG, Jagannadham MV, Srivastava SK (2013) Extracellular L-asparaginase from a protease-deficient Bacillus aryabhattai ITBHU02: Purification, biochemical characterization, and evaluation of antineoplastic activity in vitro. Appl Biochem Biotechnol 171:1759–1774. https://doi.org/10.1007/s12010-013-0455-0 PubMed DOI
Siva Lakshmi TV, Mallika DS, Amos SJ, Kondapalli K (2015) Marine L-asparaginase: a novel microbial therapeutic approach for cancer. Int J Pharm Sci Review Res 33:228–234
Srikhanta YN, Atack JM, Beacham IR, Jennings MP (2013) Distinct physiological roles for the two L-asparaginase isozymes of Escherichia coli. Biochem Biophys Res Commun 436:362–365 PubMed DOI
Sumithra TG, Reshma KJ, Christoa JP, Anusree VN, Drisyaa D, Kishor TG, Revathi DN, Sanil NK (2019) A glimpse towards cultivable hemolymph microbiota of marine crabs: untapped resource for aquatic probiotics/antibacterial agents. Aquaculture 501:119–127. https://doi.org/10.1016/j.aquaculture.2018.11.022 DOI
Tahira B, Essam AM, Muna J, Mashitah MY (2016) A comprehensive review on L-asparaginase and its applications. Appl Biochem Biotechnol 178:900–923. https://doi.org/10.1007/s12010-015-1917-3 DOI
Takemura A, Diana C, Martin P (2014) Associations and dynamics of Vibrionaceae in the environment, from the genus to the population level. Front Microbiol 5:38. https://doi.org/10.3389/fmicb.2014.00038 PubMed DOI PMC
Vimal A, Kumar A (2016) In vitro screening and in silico validation revealed key microbes for higher production of significant therapeutic enzyme L-asparaginase. Enzyme Microb Technol 98:9–17. https://doi.org/10.1016/j.enzmictec.2016.12.001 PubMed DOI
Wakil SS, Adelegan AA (2015) Screening production and optimization of L-asparaginase from soil bacteria isolated in Ibadan, South-western Nigeria. J Basic Appl Sci 11:39–51. https://doi.org/10.6000/1927-5129.2015.11.06 DOI
Wang X, Wang J (2015) Crustacean hemolymph microbiota: endemic, tightly controlled, and utilization expectable. Mol Immunol 68:404–411. https://doi.org/10.1016/j.molimm.2015.06.018 PubMed DOI
Wei Z, Wei WS, Tuan NT, Gong Y, Ma H, Zheng H, Zhang Y, Li S (2019) Two novel serine proteases from Scylla paramamosain involved in the synthesis of anti-lipopolysaccharide factors and activation of prophenoloxidase system. Fish Shellfish Immunol 84:322–332. https://doi.org/10.1016/j.fsi.2018.10.014 PubMed DOI
Weisburg WG, Barns SM, Pelletier DA, Lane DJ (1991) 16S Ribosomal DNA amplification for phylogenetic study. J Bacteriol 173:697–703 PubMed DOI PMC
Yang H, Yang M, Sun J, Guo F, Lan J, Wang X, Zhao X, Wang J (2015) Catalase eliminates reactive oxygen species and influences the intestinal microbiota of shrimp. Fish Shellfish Immunol 47:63–73. https://doi.org/10.1016/j.fsi.2015.08.021 PubMed DOI
Zhang ML, Sun YH, Chen LQ et al (2016) Symbiotic bacteria in gills and guts of Chinese mitten crab (Eriocheir sinensis) differ from the free-living bacteria in water. PLoS One 11:e0148135. https://doi.org/10.1371/journal.pone.0148135 PubMed DOI PMC
Zhang X, Zhang M, Zheng H, Ye H, Zhang X, Li S (2020) Source of hemolymph microbiota and their roles in the immune system of mud crab. Develop Comp Immunol 102:103470. https://doi.org/10.1016/j.dci.2019.103470 DOI
Zote J, Passari AK, Zothanpuia SCN, Kumar NS, Abd Allah EF, Hashem A, Alqarawi AA, Malik JA, Singh BP (2018) Phylogenetic affiliation and determination of bioactive compounds of bacterial population associated with organs of mud crab, Scylla olivacea. Saudi J Biol Sci 25:1743–1754. https://doi.org/10.1016/j.sjbs.2018.08.025 PubMed DOI PMC
Zwirzitz B, Wetzels SU, Dixon ED et al (2020) The sources and transmission routes of microbial populations throughout a meat processing facility. NPJ Biofilms Microbiomes 6:26. https://doi.org/10.1038/s41522-020-0136-z PubMed DOI PMC